HLA-A and gastric cancer: The personalized immunogenicity identification of Claudin18.2 peptides were performed in vitro on 29 advanced GC patients with matched HLA types (21 were HLA-A*0201, 12 were HLA-A*1101, 4 of them were HLA-A*0201 and HLA-A*1101 heterozygotes).